Biovet is a leading manufacturer of antibiotic feed additives and pharmaceuticals (bulk and finished dosage forms) for farm animals and pets. At the turn of the 21st century, Biovet joined the new Eastern European economy of privatized and reinvigorated enterprises. Bulgarian Pharmaceutical Company won a bid for the majority stake in Biovet from the state in the April, 2000 round of the Bulgarian privatization program. The privatization brings about exciting opportunities for Biovet in: Opening up for new business ventures and partnerships Aggressively expanding into new markets worldwide Investing in current and new product development Streamlining company operations and modernizing plant facilities Realizing synergies between Biovet and other subsidiaries of the parent company.